Role of Cytokines in Hepatitis E Virus Infection During Pregnancy
NCT01062321 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 491
Last updated 2015-04-13
Summary
Hepatitis E virus is a public health problem in several countries of the world where safe drinking water is a problem. HEV is an exclusive cause of epidemic hepatitis in general population. HEV infection occurs most frequently in rainy season. The disease affects mainly young adults in the age of 15-40 years.HEV viral infection is of particular concern in pregnancy. It is a potential disaster for mother and child. HEV infection during pregnancy is fulminant and fatal especially if it occurs in third trimester. The mortality in the second trimester is around 20% and reaches upto 45% in the third trimester.
Conditions
- Hepatitis
- Cytokines
- Pregnancy
Sponsors & Collaborators
-
Indian Council of Medical Research
collaborator OTHER_GOV -
Maulana Azad Medical College
lead OTHER
Principal Investigators
-
Dr. Ashok Kumar, MD · Maulana Azad Medical College, New Delhi-110002
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-08-31
- Primary Completion
- 2012-07-31
- Completion
- 2012-07-31
Countries
- India
Study Locations
More Related Trials
-
Efficacy of Hepatitis B Vaccine Boosters Among Neonatally Vaccinated Children in Chongqing
NCT03867643 ·Status: RECRUITING
-
Immune Function Status and the Prevalence of Hepatitis in Postpartum Pregnant Women With CHB Infection
NCT02886182 ·Status: UNKNOWN
-
Prevalence of HBV in Pregnancy
NCT05442372 ·Status: UNKNOWN
-
Seroepidemiologic Study of Spermatozoal Transmission of Hepatitis B Virus (HBV)
NCT01574521 ·Status: COMPLETED
-
Prevention for Mother-to-infant Transmission of HBV
NCT02312531 ·Status: COMPLETED ·Phase: NA
-
The Epidemic Status and Development Trend of Hepatitis C Virus Infection in Pregnant Women in Xi'an
NCT06952036 ·Status: NOT_YET_RECRUITING
-
The Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus-drug Test
NCT01312012 ·Status: UNKNOWN ·Phase: PHASE4
-
Hepatitis B Birth Dose for Newborns
NCT04870021 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study on the Effect of IVF-ET on Mother-to-child Transmission of Hepatitis B Virus
NCT03932851 ·Status: UNKNOWN
-
Mother-to-child Hepatitis D Transmission
NCT02044055 ·Status: COMPLETED
-
An Observational Study of Hepatitis C Virus in Pregnancy
NCT01959321 ·Status: COMPLETED
-
Sustained Viral Response in Patients Achieved HBsAg Level≤100 IU/ml After Completed Interferon Treatment
NCT02348502 ·Status: UNKNOWN
-
Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon Treatment
NCT02336399 ·Status: UNKNOWN
-
Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin
NCT00000580 ·Status: COMPLETED ·Phase: PHASE3
-
Vaccine+HBIG Versus Vaccine+Placebo for Newborns of HBsAg+ Mothers
NCT01412567 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children
NCT00139113 ·Status: COMPLETED ·Phase: PHASE4
-
Prevalence of HBV in Pregnant Women Attending Antenatal Care in Tanzania
NCT04325542 ·Status: COMPLETED ·Phase: NA
-
Pharmacogenomics Study on IL28B Genetic Variants in Chinese Children With Hepatitis C Virus Infection
NCT01607021 ·Status: UNKNOWN
-
Intrafamilial Transmission of Hepatitis B Virus: Frequency, Risk Factors, and Role of Hepatitis B Vaccination
NCT05523921 ·Status: UNKNOWN
-
Acute Hepatitis in Pediatrics
NCT06761261 ·Status: RECRUITING
-
Maternal Antiviral Treatment and Infants Immunoprophylaxis in the Prevention of Mother-to-child Transmission
NCT03977987 ·Status: COMPLETED
-
A Study of the Interruption on the Mother-to-child Transmission of Hepatitis B Virus (HBV MTCT)in Newborns at High Risk
NCT02901418 ·Status: UNKNOWN
-
Observational Study on Pregnant Women With Chronic Hepatitis B and Their Infants
NCT03539016 ·Status: UNKNOWN
-
Antigen-specific Immune Response to Hepatitis B Virus in Utero
NCT00845403 ·Status: UNKNOWN
-
Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students
NCT01861613 ·Status: COMPLETED ·Phase: PHASE4